CARR vs XBIO · P/E 43, rev $21.75B vs rev $1.5M
Carrier Global Corp (CARR) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the CARR and XBIO stock pages for the full models.
Not investment advice.